Related Experiment Videos
[DNA cytometry analysis in childhood tumors]
T Eckschlager1, D Pilát, R Kodet
1Klinika dĕtské onkologie FN Motol, Praha.
Casopis Lekaru Ceskych
|May 17, 1995
Summary
Flow cytometry offers an easy and fast method for DNA ploidy analysis in various cancer specimens. This technique aids in identifying malignant cells and understanding prognosis in pediatric leukemia and neuroblastoma.
Area of Science:
- Cytometry and Molecular Diagnostics
- Oncology and Cancer Research
Context:
- Flow cytometry is a valuable tool for determining cellular DNA content.
- Aneuploidy, an abnormal DNA content, is strongly associated with malignancy and impacts prognosis in various neoplasms.
- Aneuploidy is infrequently observed in benign conditions, making its detection a potential indicator of cancer.
Purpose:
- To evaluate the utility and capabilities of cytometric DNA analysis.
- To summarize initial experiences with flow cytometry for DNA content assessment.
- To demonstrate the method's applicability to a range of clinical specimens for potential users.
Summary:
- DNA content was analyzed in pediatric leukemia (blood, bone marrow), solid tumors (biopsies, paraffin-embedded tissues), and various body fluids (CSF, pleural exudates).
- Aneuploidy was frequently detected in CALLA+ acute lymphoblastic leukemia and specific types of neuroblastoma associated with favorable prognosis.
- The study highlights the method's effectiveness across diverse sample types, including unfixed and deparaffinized tissues, blood, bone marrow, CSF, and pleural effusions.
Impact:
- Establishes flow cytometry as an accessible and rapid technique for DNA ploidy testing.
- Provides evidence for the method's versatility across multiple specimen sources in oncological diagnostics.
- Supports the use of DNA ploidy analysis as a diagnostic and prognostic indicator in pediatric cancers.